Top Markets
Coin of the day
Evaxion Biotech A/S Evaxion Biotech A/S

Evaxion Biotech A/S

EVAX
주식 순위 #29741
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to... Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
주가
$3.14
마지막 동기화: 2026-08-18
시가총액
$19.83M
변동 (1일)
0.32%
변동 (1년)
3.29%
국가
DK
거래 Evaxion Biotech A/S (EVAX)

카테고리

Evaxion Biotech A/S (EVAX)의 주가 이력
최고 종가: $3.12 (2026-08-01 기준)

최저 종가: $427.70 (2021-02-01 기준)
Evaxion Biotech A/S의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -23.56%
2025 -2.32%
2024 -83.73%
2023 -64.17%
2022 -54.86%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$737.94 6.37%
CH
$1.07K -5.58%
KR